These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 28549096)

  • 1. The molecular mechanisms of obesity paradox.
    Antonopoulos AS; Tousoulis D
    Cardiovasc Res; 2017 Jul; 113(9):1074-1086. PubMed ID: 28549096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Elagizi A; Kachur S; Lavie CJ; Carbone S; Pandey A; Ortega FB; Milani RV
    Prog Cardiovasc Dis; 2018; 61(2):142-150. PubMed ID: 29981771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology.
    Chistiakov DA; Grechko AV; Myasoedova VA; Melnichenko AA; Orekhov AN
    Atherosclerosis; 2017 Aug; 263():361-368. PubMed ID: 28629772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Roles for Adipose Tissue in Cardiovascular Disease.
    Ha EE; Bauer RC
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):e137-e144. PubMed ID: 30354196
    [No Abstract]   [Full Text] [Related]  

  • 5. Epicardial Fat in the Maintenance of Cardiovascular Health.
    Wu Y; Zhang A; Hamilton DJ; Deng T
    Methodist Debakey Cardiovasc J; 2017; 13(1):20-24. PubMed ID: 28413578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between adipose tissue and the cardiovascular system: is fat always bad?
    Akoumianakis I; Antoniades C
    Cardiovasc Res; 2017 Jul; 113(9):999-1008. PubMed ID: 28582523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New obesity classification criteria as a tool for bariatric surgery indication.
    De Lorenzo A; Soldati L; Sarlo F; Calvani M; Di Lorenzo N; Di Renzo L
    World J Gastroenterol; 2016 Jan; 22(2):681-703. PubMed ID: 26811617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity Paradox in Aging: From Prevalence to Pathophysiology.
    Wang S; Ren J
    Prog Cardiovasc Dis; 2018; 61(2):182-189. PubMed ID: 29990534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
    Jia G; Aroor AR; Sowers JR
    Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
    Hill JH; Solt C; Foster MT
    Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Different Adipose Depots on Cardiovascular Disease.
    Diaz-Canestro C; Xu A
    J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S30-S39. PubMed ID: 34840259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Ortega FB; Lavie CJ
    Prog Cardiovasc Dis; 2018; 61(2):87-88. PubMed ID: 29981349
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Dysfunctional' adipose tissue in cardiovascular disease: a reprogrammable target or an innocent bystander?
    Antoniades C
    Cardiovasc Res; 2017 Jul; 113(9):997-998. PubMed ID: 28637258
    [No Abstract]   [Full Text] [Related]  

  • 15. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.
    Icli B; Feinberg MW
    Cardiovasc Res; 2017 Jul; 113(9):1024-1034. PubMed ID: 28505257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and Kidney Disease.
    Lakkis JI; Weir MR
    Prog Cardiovasc Dis; 2018; 61(2):157-167. PubMed ID: 29981350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease.
    Rafeh R; Viveiros A; Oudit GY; El-Yazbi AF
    Clin Sci (Lond); 2020 Apr; 134(7):827-851. PubMed ID: 32271386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient regulation of inflammatory signalling in obesity and vascular disease.
    Palmer TM; Salt IP
    Clin Sci (Lond); 2021 Jul; 135(13):1563-1590. PubMed ID: 34231841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of infiltrating immune cells in dysfunctional adipose tissue.
    Guzik TJ; Skiba DS; Touyz RM; Harrison DG
    Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.